BCYC Q4 2021 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-2.0% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$18M-478.0% margin

Net Income

-$18M-478.3% margin

EPS (Diluted)

$-0.63

QoQ Revenue Growth

-13.0%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$12M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$480M

Total Liabilities

$134M

Stockholders' Equity

$346M

Cash & Equivalents

$439M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	-2.0%
Gross Profit	$4M	-$6M	+160.7%
Operating Income	-$18M	-$17M	-5.7%
Net Income	-$18M	-$17M	-3.5%